-
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer : an EMBRACE analysisSpampinato, Sofia ...To identify patient- and treatment-related risk factors and dose-effects for urinary frequency and incontinence in locally advanced cervical cancer (LACC) treated with radio(chemo)therapy and ... image-guided adaptive brachytherapy (IGABT). Material and methods: Physician-assessed (CTCAE) and patient-reported (EORTC) frequency and incontinence recorded in the EMBRACE-I study were analysed. Risk factors analysis was performed in patients without bladder infiltration and with baseline morbidity available. Cox regression was used for CTCAE grade (G) % 3 and G % 2 and for EORTC "very much" and "quite a bit" or worse. Logistic regression was used for late persistent morbidity defined when CTCAE G % 1 or EORTC % "quite a bit" were scored in at least half of follow-ups. Results: Longitudinal data on 1153 and 884 patients were available for CTCAE and EORTC analysis, respectively. Median follow-up was 48[3-120] months. Crude incidence rates of G%2 were 13% and 11% for frequency and incontinence, respectively. Baseline morbidity and overweight-obesity were risk factors for both symptoms. Elderly patients were at higher risk for incontinence. Patients receiving conformal-radiotherapy were at higher risk for frequency. ICRU bladder point (ICRU-BP) dose was a stronger predictor for incontinence than bladder D2cm3. The 5-year actuarial estimate of G % 2 incontinence increased from 11% to 20% with ICRU-BP doses > 75 Gy compared to % 65 Gy. Frequency showed weaker associations with dose. Conclusion: ICRU-BP dose, in addition to clinical parameters, is a risk factor for urinary incontinence and shows a dose-effect after radio(chemo)therapy and IGABT. ICRU-BP dose should be monitored during treatment planning alongside volumetric parameters. Frequency seems associated with larger irradiated volumes.Source: Radiotherapy and oncology. - ISSN 0167-8140 (Vol. 158, 2021, str. 300-308)Type of material - article, component partPublish date - 2021Language - englishCOBISS.SI-ID - 58295299
Author
Spampinato, Sofia |
Fokdal, Lars U. |
Pötter, Richard |
Haie-Meder, Christine |
Lindegaard, Jacob Christian |
Schmid, Maximilian, radioterapevt |
Sturdza, Alina |
Jürgenliemk-Schulz, Ina Maria |
Mahantshetty, Umesh |
Šegedin, Barbara
Topics
brahiterapija |
klinične študije |
lokalno napredovali rak |
rak materničnega vratu |
clinical studies |
brachytherapy |
locally advanced cancer |
cervical cancer
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Spampinato, Sofia | |
Fokdal, Lars U. | |
Pötter, Richard | |
Haie-Meder, Christine | |
Lindegaard, Jacob Christian | |
Schmid, Maximilian, radioterapevt | |
Sturdza, Alina | |
Jürgenliemk-Schulz, Ina Maria | |
Mahantshetty, Umesh | |
Šegedin, Barbara | 27754 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.